LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
6.89
+0.06 (0.88%)
At close: Aug 13, 2025, 4:00 PM
6.71
-0.18 (-2.61%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
LifeMD Revenue
LifeMD had revenue of $62.22M in the quarter ending June 30, 2025, with 22.81% growth. This brings the company's revenue in the last twelve months to $245.56M, up 37.74% year-over-year. In the year 2024, LifeMD had annual revenue of $212.45M with 39.27% growth.
Revenue (ttm)
$245.56M
Revenue Growth
+37.74%
P/S Ratio
1.21
Revenue / Employee
$799,882
Employees
307
Market Cap
326.71M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 212.45M | 59.91M | 39.27% |
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LFMD News
- 8 days ago - LifeMD, Inc. (LFMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - LifeMD Reports Second Quarter 2025 Results - GlobeNewsWire
- 9 days ago - Medifast Announces Second Quarter 2025 Financial Results - Business Wire
- 10 days ago - LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 14 days ago - LifeMD Names COO and Promotes Two Executives - GlobeNewsWire
- 7 weeks ago - LifeMD: Inflection Into Profitability Should Drive Stock Upward - Seeking Alpha
- 7 weeks ago - LifeMD: An Overlooked GLP-1 Beneficiary - Seeking Alpha
- 7 weeks ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire